Jyong Biotech Ltd. Ordinary Shares
Support and Resistance Levels
Past performance
News About MENS
All events for MENS
All deals for MENS
Financial Ratios
Financial Statements
MENS vs Sector & Peers
About Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages. Website jyongbio.com
Headquarters New Taipei City, TP, TW